Primary record
Cholestan-3-ol, (3a,5ss)-; 5ss-Cholestan-3a-ol (8CI); (3a,5ss)-Cholestan-3-ol; 5ss-Epicholestanol; Epicoprostanol; Epicoprosterol; Epikoprosterin; NSC 18182; epi-Coprostanol; epi-Coprosterol; a-Coprostanol
- 库存
- 5,481 克
- 纯度
- 99.8 %
- CAS
- 516-92-7
化合物标识与属性
- CAS
- 516-92-7
- PubChem CID
- 91465
- SMILES
- C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C
- Canonical SMILES
- CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
名称与同义词
- Epicoprostanol
- epi-Coprostanol
- Epicoprosterol
- Epikoprosterin
- epi-Coprosterol
- 5beta-Cholestan-3alpha-ol
- .alpha.-Coprostanol
- alpha-Coprostanol
- Dihydrocholesterol
- 5b-cholestan-3a-ol
- 516-92-7
- 5-Cholestan-3-ol
- Cholestan-3-ol, (3a,5b)-
- UFH3K1F9EG
- UNII-UFH3K1F9EG
- Coprostan-3.alpha.-ol
- 5betaCholestan-3alpha-ol
- RefChem:921023
- 5|A-Cholestan-3|A-ol
- (3alpha,5beta)-cholestan-3-ol
- AC1L3M4M
- DTXSID7046700
- Cholestan-3-ol,5.beta.)-
- 5.beta.-Cholestan-3.alpha.-ol
- 5.BETA.-EPICHOLESTANOL
- NSC 18182
- NSC-18182
- orb1942306
- 3alpha-Hydroxy-5beta-cholestane
- EPICOPROSTANOL [USP-RS]
- CHEMBL1998721
- DTXCID5026700
- SCHEMBL29423003
- Cholestan-3-ol, (3alpha,5beta)-
- CTK1H0779
- C27H48O
- C32H58O
- 3-alpha-hydroxy-5beta-cholestanol
- CHEBI:171890
- QYIXCDOBOSTCEI-KKFSNPNRSA-N
- Cholestan-3-ol, (3|A,5|A)-
- CID91465
- NSC18182
- ZINC4683759
- Tox21_112538
- AR-1G7252
- C32-H58-O
- LMST04030110
- MFCD00064143
- NCGC00167541-01
- 5beta-Cholestan-3alpha-ol, >=95%
- Cholestan-3-ol, (3.alpha.,5.beta.)-
- (3.alpha.,5.beta.)-Cholestan-3-ol
- FE64063
- HY-W127498
- MSK170388-100M
- CAS-516-92-7
- J39.847K
- Cholestan-3-ol, (3alpha,5beta)- (9CI)
- DB-242217
- CS-0185726
- NS00124865
- Epicoprostanol Solution in Methanol, 100ug/mL
- G77765
- (3R,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
- Q27291059
- Epicoprostanol, United States Pharmacopeia (USP) Reference Standard
- (1R,3aS,3bR,5aR,7R,9aS,9bS,11aR)-9a,11a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-hexadecahydro-1H-cyclopenta[a]phenanthren-7-ol
- (3R,5R,8R,9S,10S,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol
- (3R,5R,8R,9S,10S,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
- 52809-10-6
- Cholestan-3-ol, (3a,5ss)-; 5ss-Cholestan-3a-ol (8CI); (3a,5ss)-Cholestan-3-ol; 5ss-Epicholestanol; Epicoprostanol; Epicoprosterol; Epikoprosterin; NSC 18182; epi-Coprostanol; epi-Coprosterol; a-Coprostanol